Prescription stimulant use among the United States' (US) older adult population is increasing, yet little is known about the cardiovascular safety profiles of the two major prescription stimulant classes, methylphenidate (MPD) and amphetamine (AMP).
Keywords: OIder adults, amphetamine, cardiovascular events, methylphenidate, mortality, prescription stimulants
Pharmacoepidemiology and drug safety
Journal Article
English
42003446
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.